Autoantibodies to BIRC5 and MYC were measured in cervical cancer patients and a control group.
•
There was a significant difference in circulating levels of these autoantibodies in the patient and control groups.
•
ROC analysis suggests that anti-BIRC5 IgG has a higher sensitivity than anti-MYC IgG.
•
Anti-BIRC5 IgG could serve as a biomarker for the early diagnosis of cervical cancer.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.